Yearly Archives: 2020

Nifty Weekly Expiry Analysis

By | November 11, 2020 10:49 pm

FII bought 2.8 K contract of Index Future worth 238 cores, Net OI has increased by 9.9  K contract,6.3 K Long contract were added by FII and 3.5 K Shorts were added by FII. Net FII Long Short ratio at 2.9 So FII used rise to enter longs and enter shorts. As Discussed in Last… Read More »

Bank Nifty Weekly Expiry Analysis

By | November 11, 2020 8:38 pm

As Discussed in Last Analysis Bank Nifty continued its strong momentum on upside, Today is important astro date and break of High and low of today can see move of 350-500 points. Bulls need to move above 28656 for a move back to 28800/28944/29088. Bears will get active below 28512 for a move back to… Read More »

Trading using Time Cycle:Hindpetro,M&M,Reliance

By | November 11, 2020 7:34 am

HindPetro Positional  Traders can use the below mentioned levels Close above 214 Target 222 Intraday Traders can use the below mentioned levels Buy above 214 Tgt 216, 218 and 220 SL 212 Sell below  210 Tgt 208.5, 206 and 204 SL 212 Reliance Positional  Traders can use the below mentioned levels Close below 2070 Target… Read More »

Bank Nifty Analysis as Mercury goes Ingress

By | November 10, 2020 9:34 pm

As Discussed in Last Analysis  As per gann analysis Range of 28070-28225 will act as a resistance zone,so longs should use this range to book profits as and when it come. Bears will get active below 27450 for a move back to 27200/27000/26873. Bank Nifty continued its strong momentum on upside, Today is important astro date… Read More »

Coronavirus Vaccine Update:Bank Nifty Analysis

By | November 9, 2020 9:33 pm

As Discussed in Last Analysis  26830 Bullish target done and Gann date showed its effect with move of 500 points. Now Bulls need to move 27050 for move back to 27300/27500/27774. Bears will get active below 26490 for a move back to 26338/26000/25877.  Bank Nifty made low of 27068 so bulls go entry and did… Read More »

PFIZER AND BIONTECH ANNOUNCE VACCINE CANDIDATE AGAINST COVID-19

By | November 9, 2020 7:14 pm

NEW YORK & MAINZ, GERMANY–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC)… Read More »